Suppr超能文献

初始肾切除术后局限性肾细胞癌患者无病生存预测总生存:监测、流行病学和最终结果-医疗保险数据的回顾性分析。

Disease-free survival as a predictor of overall survival in localized renal cell carcinoma following initial nephrectomy: A retrospective analysis of Surveillance, Epidemiology and End Results-Medicare datac.

机构信息

University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.

Analysis Group, Inc., Boston, Massachusetts, USA.

出版信息

Int J Urol. 2023 Mar;30(3):272-279. doi: 10.1111/iju.15104. Epub 2023 Feb 14.

Abstract

OBJECTIVES

This study aimed to assess whether disease-free survival (DFS) may serve as a predictor for long-term survival among patients with intermediate-high risk or high risk renal cell carcinoma (RCC) post-nephrectomy when overall survival (OS) is unavailable.

METHODS

The Surveillance, Epidemiology and End Results-Medicare database (2007-2016) was used to identify patients with non-metastatic intermediate-high risk and high risk RCC post-nephrectomy. Landmark analysis and Kendall's τ were used to evaluate the correlation between DFS and OS. Multivariable regression models were used to quantify the incremental OS post-nephrectomy associated with increased time to recurrence among patients with recurrence, adjusting for baseline covariates.

RESULTS

A total of 643 patients were analyzed; mean age of 75 years; >95% of patients had intermediate-high risk RCC at diagnosis; 269 patients had recurrence post-nephrectomy. For patients with versus without recurrence at the landmark points of 1, 3, and 5 years post-nephrectomy, the 5-year OS were 37.0% versus 70.1%, 42.3% versus 72.8%, and 53.2% versus 78.6%, respectively. The Kendall's τ between DFS and OS post-nephrectomy was 0.70 (95% CI: 0.65, 0.74; p < 0.001). After adjusting for baseline covariates, patients with one additional year of time to recurrence were associated with 0.73 years longer OS post-nephrectomy (95% CI: 0.40, 1.05; p < 0.001).

CONCLUSION

The significant positive association of DFS and OS among patients with intermediate-high risk and high risk RCC post-nephrectomy from this study supports the use of DFS as a potential predictor of OS for these patients when OS data are immature.

摘要

目的

本研究旨在评估在无法获得总生存(OS)数据的情况下,无病生存(DFS)是否可作为肾细胞癌(RCC)患者肾切除术后中高危或高危患者长期生存的预测指标。

方法

利用监测、流行病学和最终结果-医疗保险数据库(2007-2016 年),确定肾切除术后非转移性中高危和高危 RCC 患者。采用里程碑分析和 Kendall's τ评估 DFS 与 OS 之间的相关性。在存在复发的患者中,使用多变量回归模型,通过调整基线协变量,量化复发后肾切除术后与复发时间增加相关的额外 OS。

结果

共分析了 643 例患者,平均年龄为 75 岁,诊断时 95%以上的患者为中高危 RCC,269 例患者在肾切除术后复发。对于在肾切除术后 1、3 和 5 年里程碑点有和无复发的患者,5 年 OS 分别为 37.0%和 70.1%、42.3%和 72.8%、53.2%和 78.6%。DFS 与 OS 之间 Kendall's τ 为 0.70(95%CI:0.65,0.74;p<0.001)。调整基线协变量后,复发时间每增加 1 年,患者复发后 OS 延长 0.73 年(95%CI:0.40,1.05;p<0.001)。

结论

本研究中,肾切除术后中高危和高危 RCC 患者的 DFS 与 OS 之间具有显著的正相关性,支持在 OS 数据不成熟时,将 DFS 作为这些患者 OS 的潜在预测指标。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11ca/11524080/29c39c31ba11/IJU-30-272-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验